Aripiprazole Augmentation in the Treatment of Military-Related PTSD with Major Depression: a retrospective chart review
<p>Abstract</p> <p>Background</p> <p>In this chart review, we attempted to evaluate the benefits of adding aripiprazole in veterans with military-related PTSD and comorbid depression, who had been minimally or partially responsive to their existing medications.</p>...
Main Authors: | Fikretoglu Deniz, Richardson J Don, Liu Aihua, McIntosh Diane |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2011-05-01
|
Series: | BMC Psychiatry |
Online Access: | http://www.biomedcentral.com/1471-244X/11/86 |
Similar Items
-
Augmentation treatment in major depressive disorder: focus on aripiprazole
by: J Craig Nelson, et al.
Published: (2008-08-01) -
A Case of Comorbid PTSD and Posttraumatic OCD Treated with Sertraline-Aripiprazole Augmentation
by: Rodolfo Rossi, et al.
Published: (2020-01-01) -
Long-term safety and tolerability of open-label aripiprazole augmentation of antidepressant therapy in major depressive disorder
by: Berman R, et al.
Published: (2011-05-01) -
A retrospective study of predictive factors for effective aripiprazole augmentation of antidepressant therapy in treatment-resistant depression
by: Sugawara H, et al.
Published: (2016-05-01) -
A group randomized control trial to test the efficacy of the Road to Mental Readiness (R2MR) program among Canadian military recruits
by: Deniz Fikretoglu, et al.
Published: (2019-10-01)